DGAP-Adhoc

Carl Zeiss Meditec reports revenue growth of 3.8% for 9M 2013/14 - EBIT close to previous year's level - EPS decline by 13%

Carl Zeiss Meditec AG / Key word(s): 9-month figures/Preliminary Results

18.07.2014 13:28

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Jena, 18 July 2014: Carl Zeiss Meditec AG (ISIN: DE0005313704) reports
revenue of approx. EUR 673.7m after 9M 2013/14 based on preliminary data.
This corresponds to a growth rate of 3.8% vs. the previous year's level.
Growth at constant currencies amounted to 7.3%.

Earnings before interest and taxes (EBIT) amounted to EUR 92.1m after 9M
2013/14. This corresponds to a slight decline of 1.4% vs. the previous
year's level.

Earnings per share (EPS) after 9M 2013/14 amounted to EUR 0.71. This
corresponds to a decline of approx. 13% vs. the previous year's level. The
decline was mainly attributable to a negative result from currency hedging
within the third quarter, compared to a markedly positive result from
currency hedging in the previous year's quarter.

The 9M 2013/14 quarterly report will be published on 14 August 2014.


18.07.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------

Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena
Germany
Phone: [phone]
Fax: [phone]
E-mail: [e-mail],[e-mail]
Internet: www.meditec.zeiss.de
ISIN: DE0005313704
WKN: 531370
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, Hannover, München, Stuttgart

End of Announcement DGAP News-Service

---------------------------------------------------------------------------